|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 亚太地区炎症性肠病处理共识意见(一)显示文摘虽然目前亚太地区尚无炎症性肠病(IBD)的大规模流行病学资料,但一系列研究显示其发病率和患病率呈上升趋势,与西方国家相比仍呈滞后现象,溃疡性结肠炎(UC)的发病率仍较克罗恩病(CD)高。除地域差异外,在一些多民族国家中,IBD尚可见种族差异。亚太地区IBD的遗传背景有异于西方国家,如据报道该地区CD患者未检出NOD2/CARD15变异。一般而言,该地区IBD患者的临床过程似不如西方国家严重。亚太地区IBD的诊断存在一些特殊问题。如缺乏IBD诊断金标准,存在多种小肠结肠炎,与IBD临床表现相似,使鉴别诊断特别困难。迄今为止,亚太地区IBD的诊断标准多采用西方国家的诊断标准。诊断必须逐步排除非IBD的小肠结肠炎,确诊应有典型的组织学表现,某些患者需借助随访和诊断性治疗才能确诊。进一步研究IBD发病机制将有助于开发更好的诊断标记物。亚太地区IBD的治疗亦存在特殊问题。由于诊断困难,IBD患者常未能及时接受适当的药物治疗,但该地区仍广泛采用药物治疗方案。结合西方指南和本地经验可制定类似的处理原则,以利诱导缓解和维持缓解。提倡逐级使用基于病变范围、活动性和严重度的阶梯式治疗方案,对不同病例采用综合性、个体化的方法。随着对IBD发病机制和亚太地区IBD独特性的深入理解,合理、实用的药物治疗指南和应用生物制剂治疗将改善该地区IBD的治疗前景。 | 欧阳钦 Rakesh Tandon KL Goh 潘国宗 KM Fock Claudio Fiocchi SK Lam 萧树东 张虎 梁红亮 王玉芳 | 2006 | 胃肠病学2006，11，4： | 123 |
| 2 | 亚太地区炎症性肠病处理共识意见(二)显示文摘 | 欧阳钦 Rakesh Tandon KL Goh 潘国宗 KM Fock Claudio Fiocchi SK Lam 萧树东 张虎(翻译) 梁红亮(翻译) 王玉芳(翻译) 欧阳钦(审校) | 2006 | 胃肠病学2006，11，5： | 47 |
| 3 | 慢性胰腺炎──病因、发病机制及治疗的认识现状显示文摘 | Rakesh K Tandon Pramod K Garg 蒋晓玲 | 2002 | 胃肠病学2002，7，1： | 6 |
| 4 | World Gastroenterology Organisation Global Guideline: Constipation—A Global Perspective显示文摘 | Greger Lindberg Saeed S. Hamid Peter Malfertheiner Ole Ostergaard Thomsen Luis Bustos Fernandez James Garisch Alan Thomson Khean-Lee Goh Rakesh Tandon Suliman Fedail Benjamin C.Y. Wong Aamir Ghafoor Khan Justus H. Krabshuis Anton LeMair | 2011 | Journal of Clinical Gastroenterology2011，，6： | 3 |
| 5 | The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis显示文摘 | Ajit Sood Vandana Midha Govind K. Makharia Vineet Ahuja Dinesh Singal Pooja Goswami Rakesh K. Tandon | 2009 | Clinical Gastroenterology and Hepatology2009，，11： | 2 |
| 6 | The emergence of inflammatory bowel disease in the Asian Pacific region显示文摘 | Qin Ouyang Rakesh Tandon Khean-Lee Goh Choon Jin Ooi Haruhiko Ogata Claudio Fiocchi | 2005 | Current Opinion in Gastroenterology2005，，4： | 2 |
| 7 | A Randomized Controlled Trial of Antioxidant Supplementation for Pain Relief in Patients With Chronic Pancreatitis显示文摘 | Payal Bhardwaj Pramod Kumar Garg Subir Kumar Maulik Anoop Saraya Rakesh Kumar Tandon Subrat Kumar Acharya | 2009 | Gastroenterology2009，，1： | 2 |
| 8 | Measuring intravariceal pressure显示文摘 | Rakesh K. Tandon Nripen Saikia | 2009 | Gastrointestinal Endoscopy2009，，3： | 1 |
| 9 | Stress and the gastrointestinal tract显示文摘 | Vikram Bhatia Rakesh Tandon | 2005 | J Gastroenterology and Hepatology2005，20，： | 1 |
| 10 | A Randomized Controlled Trial of Antioxidant Supplementation for Pain Relief in Patients With Chronic Pancreatitis显示文摘 | Payal Bhardwaj Pramod Kumar Garg Subir Kumar Maulik Anoop Saraya Rakesh Kumar Tandon Subrat Kumar Acharya | 2009 | Gastroenterology2009，，1： | 1 |
| 11 | Association of extent and infection of pancreatic necrosis with organ failure and death in acute necrotizing pancreatitis显示文摘 | Pramod Kumar Garg Kaushal Madan Girish Kumar Pande Sudeep Khanna Garipati Sathyanarayan Narendra Prasad Bohidar Rakesh Kumar Tandon | 2005 | Clinical Gastroenterology and Hepatology2005，，2： | 1 |
| 12 | The effects of medium-chain triglycerides in the short bowel syndrome显示文摘 | Rakesh K. Tandon MD John B. Rodgers MD John A. Balint MB | 1972 | The American Journal of Digestive Diseases1972，，3： | 1 |
| 13 | Management of acute severe ulcerative colitis显示文摘The management strategy of acute severe ulcerative colitis has evolved over the past decade from being entirely restricted to twin choices of intravenous steroids or colectomy to include colon rescue therapies like cyclosporin as well as infliximab. However it still remains a medical emergency requiring hospitalization and requires care from a multidisciplinary team comprising of a gastroenterologist and a colorectal surgeon. The frame shift in management has been the emphasis on time bound decision making with an attempt to curtail the mortality rate to below 1%. Intravenous corticosteroids are the mainstay of therapy. Response to steroids should be assessed at day 3 of admission and partial/non-responders should be considered for alternative medical therapy/surgery. Medical rescue therapies include intravenous cyclosporin and infliximab. Cyclosporin is administered in a dose of 2 mg/kg per day and infliximab is administered as a single dose intravenous infusion of 5 mg/kg. Approximately 75% patients have short term and 50% patients have long term response to cyclosporin. Long term response to cyclosporin is improved in patients who are thiopurine na?ve and are started on thiopurines on day 7. Infliximab also has a response rate of approximately 70% in short term and 50% in long term. Both cyclosporin and infliximab are equally efficacious medical rescue therapies as demonstrated in a recent randomized control trial. Patientsnot responding to infliximab or cyclosporin should be considered for colectomy. | Saurabh Kedia Vineet Ahuja Rakesh Tandon | 2014 | World Journal of Gastrointestinal Pathophysiology2014，5，4： | 1 |
| 14 | Micropropagation and slow growth conservation of cardamom (Elettaria cardamomum Maton)显示文摘 | Rishi K. Tyagi Rajni Goswami Rajkumari Sanayaima Rakesh Singh Rajesh Tandon Anuradha Agrawal | 2009 | In Vitro Cellular & Developmental Biology - Plant2009，，6： | 1 |
| 15 | The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis显示文摘 | Ajit Sood Vandana Midha Govind K. Makharia Vineet Ahuja Dinesh Singal Pooja Goswami Rakesh K. Tandon | 2009 | Clinical Gastroenterology and Hepatology2009，，11： | 1 |
| 16 | A Randomized Controlled Trial of Antioxidant Supplementation for Pain Relief in Patients With Chronic Pancreatitis显示文摘 | Payal Bhardwaj Pramod Kumar Garg Subir Kumar Maulik Anoop Saraya Rakesh Kumar Tandon Subrat Kumar Acharya | 2009 | Gastroenterology2009，，1： | 1 |
| 17 | Colorectal neoplasia in Asia: a multicenter colonoscopy survey in symptomatic patients 显示文摘 | Wai K. Leung Khek Yu Ho Won-ho Kim James Y.W. Lau Euan Ong Ida Hilmi Pinit Kullavanijaya Cheng-yi Wang Chu-jun Li Rikiyu Fujita Murdan Abdullah Rakesh Tandon Joseph J.Y. Sung | 2006 | Gastrointestinal Endoscopy2006，，： | 1 |
| 18 | CAsia-pacific Consensus on treatment of inflammatory bowl disease 显示文摘 | Ou Yangqin Rakesh Tandon KL Goh | 2006 | Gas- troenterology2006，11，： | 1 |
| 19 | A Randomized Controlled Trial of Antioxidant Supplementation for Pain Relief in Patients With Chronic Pancreatitis显示文摘 | Payal Bhardwaj Pramod Kumar Garg Subir Kumar Maulik Anoop Saraya Rakesh Kumar Tandon Subrat Kumar Acharya | 2009 | Gastroenterology2009，，1： | 1 |
| 20 | 一例罕见的感染性结肠炎显示文摘Methicillin-resistant Staphylococcus aureus(MRSA)is responsible for numerous infectious processes.Gastrointestinal tract involvement is rather rare and only a handful of cases of MRSA colitis have been reported in North America.We present a case of MRSA colitis in an adult without apparent risk factors.Abdominal computed tomography(CT)showed thickening of the sigmoid colon,indicative of colitis,and empiric therapy with ciprofloxacin and metronidazole was started.Initial work-up for infection-including blood and stool cultures,and stool Clostridium difficile toxin assay-was negative.The patient’s clinical status improved but his diarrhea did not abate.Repetition of stool culture demonstrated luxuriant growth of MRSA sensitive to vancomycin.Oral vancomycin was administered and the patient’s symptoms promptly ceased. | Aditya Kalakonda Shashank Garg Suraj Tandon Rakesh Vinayak Sudhir Dutta | 2016 | Gastroenterology Report2016，4，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员